Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.20.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
NET CASH PROVIDED BY OPERATING ACTIVITIES $ 557 $ 1,269
INVESTING ACTIVITIES    
Purchase of medical equipment and property (4,536) (3,535)
Proceeds from sale of medical equipment and property 500 764
NET CASH USED IN INVESTING ACTIVITIES (4,036) (2,771)
FINANCING ACTIVITIES    
Principal payments on term loans, equipment line, revolving credit facility and other financing (9,229) (929)
Cash proceeds from 2019 equipment line and revolving credit facility 10,468
Debt issuance costs (3)
Common stock repurchased to satisfy statutory withholding on employee stock-based compensation plans (426) (37)
Cash proceeds - stock plans 74 53
Common stock - issued 250
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES 1,137 (916)
Net change in cash and cash equivalents (2,342) (2,418)
Cash and cash equivalents, beginning of period 2,647 4,318
Cash and cash equivalents, end of period $ 305 $ 1,900